These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 23535511
1. Platelet concentrates, from whole blood or collected by apheresis? van der Meer PF. Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511 [Abstract] [Full Text] [Related]
2. A critical comparison of platelet preparation methods. Vassallo RR, Murphy S. Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436 [Abstract] [Full Text] [Related]
3. [Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?]. Lozano ML, Rivera J, Vicente V. Med Clin (Barc); 2012 May 05; 138(12):528-33. PubMed ID: 21807386 [Abstract] [Full Text] [Related]
5. Pooled platelet concentrates: an alternative to single donor apheresis platelets? Pietersz RN. Transfus Apher Sci; 2009 Oct 05; 41(2):115-9. PubMed ID: 19716340 [Abstract] [Full Text] [Related]
7. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products]. Hitzler WE. Clin Lab; 2014 Oct 05; 60(4):S1-39. PubMed ID: 24779310 [Abstract] [Full Text] [Related]
11. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis. Vasconcelos E, Figueiredo AC, Seghatchian J. Transfus Apher Sci; 2003 Aug 05; 29(1):13-6. PubMed ID: 12877887 [Abstract] [Full Text] [Related]
13. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates. Singh S, Shams Hakimi C, Jeppsson A, Hesse C. Transfus Apher Sci; 2017 Dec 05; 56(6):870-874. PubMed ID: 29126740 [Abstract] [Full Text] [Related]
14. Do manual and automated processes with distinct additive solutions affect whole blood-derived platelet components differently? Nguyen KA, Chavarin P, Arthaud CA, Cognasse F, Garraud O. Blood Transfus; 2013 Jan 05; 11(1):152-3. PubMed ID: 22871820 [No Abstract] [Full Text] [Related]
15. Therapeutic Effect of Apheresis and Buffy Coat-Derived Platelet Concentrates. Zimmermann R. Clin Lab; 2024 Aug 01; 70(8):. PubMed ID: 39193973 [No Abstract] [Full Text] [Related]
18. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections. Sloand EM, Yu M, Klein HG. Transfusion; 1996 Aug 01; 36(11-12):955-9. PubMed ID: 8937403 [Abstract] [Full Text] [Related]
19. The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets. Vamvakas EC. Clin Lab; 2010 Aug 01; 56(7-8):263-79. PubMed ID: 20857891 [Abstract] [Full Text] [Related]
20. Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response. Thuku NW, Shikuku K, Mbugua A. Pan Afr Med J; 2017 Aug 01; 27():226. PubMed ID: 28979628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]